Although the depth mechanism of INSR mutation in ITP patients is still uncover, the exon mutations of INSR and PTEN may be involved in the PI3K/Akt signaling pathway, further affecting the expression of downstream molecules and eventually participating in the pathogenesis of ITP. The gene discussed is INSR; the disease is autoimmune thrombocytopenic purpura.